WCM
IDXX icon

Winthrop Capital Management’s Idexx Laboratories IDXX Stock Holding History

Winthrop Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Hold
3
– – ﹤0.01% 285
2026
Q1 		$2K Hold
3
– – ﹤0.01% 280
2025
Q4 		$2K Hold
3
– – ﹤0.01% 288
2025
Q3 		$2K Hold
3
– – ﹤0.01% 262
2025
Q2 		$2K Hold
3
– – ﹤0.01% 266
2025
Q1 		$1K Hold
3
– – ﹤0.01% 283
2024
Q4 		$1K Hold
3
– – ﹤0.01% 295
2024
Q3 		$2K Hold
3
– – ﹤0.01% 133
2024
Q2 		$1K Hold
3
– – ﹤0.01% 145
2024
Q1 		$2K Buy
+3
New +$1.64K ﹤0.01% 127

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Winthrop Capital Management's IDXX Position: Q2 2026 in Review

Winthrop Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 3 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Winthrop Capital Management first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Winthrop Capital Management held 3 shares of Idexx Laboratories worth $2K as of Q2 2026.
  • Winthrop Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Winthrop Capital Management's portfolio in Q2 2026, its #285 holding.
  • Winthrop Capital Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.